It’s because they don’t have a good causality link for adverse effect. If something bad happens, you’re not sure it’s because of the treatment.
So in the accounting, you take everything adverse against the treatment, wether it’s the placebo or the medicine under test, and you compare the difference between the two as rate of adverse effect for the medicine under test. And then there is a giant poker game to balance the benefits and the risks.